SCHEMBL2463728

SCHEMBL2463728

c1cc2cc(-c3cnoc3)ccc2[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.54
CYP17A1 P05093 1/20 0.48
CYP11B1 P15538 1/20 0.48
CYP11B2 P19099 1/20 0.48
MAP3K11 Q16584 1/20 0.47
BRD4 O60885 1/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
PSMB8 P28062 1/20 0.46
FYN P06241 1/20 0.46
NISCH Q9Y2I1 1/20 0.45
PIP4K2A P48426 1/20 0.43
PIP4K2B P78356 1/20 0.43
CASP3 P42574 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
APP P05067 1/20 0.43
HCRTR1 O43613 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2455111 0.87 BRD4 (0.47) NPC1BRD4FYNPIP4K2APIP4K2B
SCHEMBL5850255 0.80 NPC1 (0.79) NPC1CYP17A1CYP11B1CYP11B2MAP3K11
SCHEMBL2459978 0.77 GSK3B (0.60) LRRK2CLK1DYRK1ADYRK2DYRK1B
SCHEMBL6655349 0.74 NPC1 (0.59) NPC1CYP17A1CYP11B1CYP11B2MAP3K11
SCHEMBL2458511 0.73 NPC1 (0.50) NPC1CYP17A1CYP11B1CYP11B2MAP3K11
SCHEMBL2457847 0.72 NPC1 (0.58) NPC1CYP17A1CYP11B1CYP11B2MAP3K11
SCHEMBL2457387 0.72 NPC1 (0.58) NPC1CYP17A1CYP11B1CYP11B2MAP3K11
SCHEMBL3956542 0.72 CYP17A1 (0.76) NPC1CYP17A1CYP11B1CYP11B2MAP3K11
SCHEMBL12680497 0.71 NPC1 (0.56) NPC1CYP17A1CYP11B1CYP11B2MAP3K11
SCHEMBL2455118 0.71 NPC1 (0.51) NPC1CYP17A1CYP11B1CYP11B2BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-09-29 US disclosed
WO-2010068287-A2 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY ANGION BIOMEDICA CORP. (US) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY HGF, HDGF, MET NPC1 1244/4885CYP17A1 2168/4885CYP11B1 2027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.